Research Article

[Retracted] Chemotherapy with a TP Regimen in Combination with Stereotactic Radiotherapy Could Significantly Optimize the Clinical Efficacy of NSCLC Treatment

Table 8

Investigation results of adverse reactions in patients.

GroupLeukocytopeniaHemoglobin decreaseGastrointestinal reactionLiver function impairmentRenal impairment

Observation group1 (2.50)001 (2.50)1 (2.50)
Control group1 (2.50)2 (5.00)2 (5.00)1 (2.50)4 (10.00)
χ25.1285.1284.800
0.0240.0240.029